Pupil Response in Patients on Opioids.
NCT02247024 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 63
Last updated 2019-01-29
Summary
Evaluation of pupillary reflex in patients on high-dose opioids. Clinical assessment of pain intensity, sedation score, and other side effects of opioids. Measurements of the concentration of opioids and their active metabolites in blood.
Conditions
- Chronic Pain
- Impaired Pupillary Reflex
- Opioid-Related Disorders
Sponsors & Collaborators
-
Oslo University Hospital
lead OTHER
Principal Investigators
-
Ulf E Kongsgaard, MD PhD · Oslo University Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-01-31
- Primary Completion
- 2018-08-31
- Completion
- 2018-11-30
Countries
- Norway
Study Locations
More Related Trials
-
Non-intrusive Detection of Temporary Neurologic Impairment by Opioids
NCT05489601 ·Status: COMPLETED
-
Effects of Buprenorphine on Ulnar Nerve Motor Block
NCT00949299 ·Status: TERMINATED ·Phase: PHASE4
-
POINT - Preventing an Opioid Epidemic in Norway: Focusing on Treatment of Chronic Pain
NCT05828121 ·Status: UNKNOWN ·Phase: NA
-
Medications for Opioid Use Disorder Photosensitive Retinal Ganglion Cell Function, Sleep, and Circadian Rhythms: Implications for Treatment
NCT06104280 ·Status: RECRUITING
-
Multi-System Analysis of Opioid Receptor Binding
NCT05528848 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Pharmacokinetics and Pharmacodynamics of Buprenorphine in Healthy Volunteers
NCT00347815 ·Status: UNKNOWN ·Phase: PHASE1
-
Buprenorphine's Dose Response Curve
NCT00460239 ·Status: COMPLETED ·Phase: PHASE2
-
Long-Term Opioid Therapy in Chronic Non-Cancer Pain: Risks and Benefits
NCT06063902 ·Status: ENROLLING_BY_INVITATION
-
Effects of Buprenorphine and Naloxone in Opiate Addicts - 4
NCT00000355 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Unintended Prolonged Opioid Use
NCT04024397 ·Status: COMPLETED
-
Reversal of Opioid-induced Respiratory Depression With Opioid Antagonists
NCT05338632 ·Status: RECRUITING ·Phase: PHASE1
-
A Randomised, Double Blind, Placebo and Active Controlled, Double Dummy,Parallel Group Study to Determine the Safety and Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Subjects With Moderate to Severe, Chronic Nonmalignant Pain
NCT01971632 ·Status: COMPLETED ·Phase: PHASE3
-
Naltrexone vs Buprenorphine-Naloxone for Opioid Dependence in Norway
NCT01717963 ·Status: COMPLETED ·Phase: PHASE3
-
Pilot Research on Opioid Use Disorder
NCT04244227 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Return to Work - Will Brief Intervention Reduce Opioid-induced Back Pain?
NCT05437861 ·Status: UNKNOWN ·Phase: NA
-
Analgesic Response to Opioid Analgesics in Buprenorphine-Maintained Individuals
NCT02136784 ·Status: UNKNOWN ·Phase: NA
-
Pharmacokinetics and Pharmacodynamics of a New Formulation of Nasal Naloxone for Prehospital Use
NCT02307721 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Opioid Antagonism in Individuals Ascertained Through the Partners HealthCare Biobank
NCT04975347 ·Status: COMPLETED ·Phase: PHASE1
-
Buprenorphine for Cancer Pain
NCT05910190 ·Status: UNKNOWN ·Phase: PHASE4
-
Buprenorphine Combination Tablet Feasibility - 1
NCT00000298 ·Status: COMPLETED ·Phase: PHASE2
-
Low-dose Versus a High-dose Sublingual Buprenorphine Induction
NCT05944952 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Prescription Opioid Effects in Abusers Versus Non-Abusers
NCT00158184 ·Status: COMPLETED ·Phase: PHASE2
-
Increasing Naloxone Access for Persons Who Use Opioids
NCT04303000 ·Status: COMPLETED ·Phase: PHASE4
-
An Explorative Pilot Study of a New Mobile Phone Application Measuring Eye Parameters of Eyes in Patients With SUD
NCT05737550 ·Status: COMPLETED ·Phase: NA
-
Blockade Efficacy of Buprenorphine/Naloxone For Opioid Dependence
NCT00134888 ·Status: COMPLETED ·Phase: NA